100
Participants
Start Date
December 1, 2024
Primary Completion Date
September 30, 2027
Study Completion Date
September 30, 2027
Teclistamab
Intervention is part of standard clinical care, as Tecvayli/Teclistamab is reimbursed for this group of patients.
RECRUITING
Institut Jules Bordet, Brussels
RECRUITING
UCL Saint Luc, Brussels
RECRUITING
Universitair Ziekenhuis Antwerpen (UZA), Edegem
NOT_YET_RECRUITING
Imelda, Bonheiden
RECRUITING
UZ Leuven Gasthuisberg, Leuven
RECRUITING
Jessa Ziekenhuis, Hasselt
RECRUITING
CHR Citadelle, Liège
RECRUITING
CHU Liège, Liège
RECRUITING
CHU UCL Namur, Yvoir
RECRUITING
Grand Hôpital de Charleroi, Charleroi
RECRUITING
CHU Ambroise Paré, Mons
RECRUITING
EpiCURA, Hornu
RECRUITING
AZ Groeninge, Kortrijk
RECRUITING
AZ Delta, Roeselare
RECRUITING
Algemeen Ziekenhuis Maria Middelares (AZMM), Ghent
RECRUITING
Universitair Ziekenhuis Gent (UZ Gent), Ghent
RECRUITING
Vitaz, Sint-Niklaas
Collaborators (1)
Janssen Pharmaceutica
INDUSTRY
Universitaire Ziekenhuizen KU Leuven
OTHER